Abstract | BACKGROUND AND OBJECTIVE: Anterior chamber migration of the dexamethasone intravitreal implant (Ozurdex; Allergan, Irvine, CA) may lead to corneal edema and elevated intraocular pressure, warranting removal of the implant. MATERIALS AND METHODS: A 59-year-old patient with a history of prior vitrectomy, a posterior chamber intraocular lens with a disrupted posterior capsule, and a large inferior peripheral iridectomy presented with decreased vision due to corneal edema following dexamethasone intravitreal implant injection. The authors describe their technique for implant removal, which uses standard vitreoretinal instrumentation, viscoelastic, a modified Sheets glide, and angled forceps in order to avoid fragmentation of the implant and limit iatrogenic morbidity. RESULTS: The implant was successfully explanted. Postoperatively, the patient experienced improvement in the corneal edema, and after Descemet's stripping endothelial keratoplasty achieved a final best corrected visual acuity of 20/60 at final 12-month follow-up. CONCLUSION:
|
Authors | Christopher R Stelton, Justin Townsend, Luke T Peterson, Rahul N Khurana, Steven Yeh |
Journal | Ophthalmic surgery, lasers & imaging retina
(Ophthalmic Surg Lasers Imaging Retina)
2015 Jul-Aug
Vol. 46
Issue 7
Pg. 756-9
ISSN: 2325-8179 [Electronic] United States |
PMID | 26247457
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright 2015, SLACK Incorporated. |
Chemical References |
- Drug Implants
- Glucocorticoids
- Dexamethasone
|
Topics |
- Anterior Chamber
(pathology, surgery)
- Corneal Edema
(chemically induced, surgery)
- Descemet Stripping Endothelial Keratoplasty
- Device Removal
(methods)
- Dexamethasone
(adverse effects)
- Drug Implants
- Foreign-Body Migration
(etiology, surgery)
- Glucocorticoids
(adverse effects)
- Humans
- Intravitreal Injections
- Macular Edema
(drug therapy)
- Male
- Middle Aged
- Ophthalmologic Surgical Procedures
- Vitreous Body
|